Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes

R. B Schnabel, L. Pecen, D. Engler, M. Lucerna, JM. Sellal, FM. Ojeda, R. De Caterina, P. Kirchhof,

. 2018 ; 104 (19) : 1608-1614. [pub] 20180317

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19012772
E-zdroje Online Plný text

NLK ProQuest Central od 1996-01-01 do Před 3 měsíci
Health & Medicine (ProQuest) od 1996-01-01 do Před 3 měsíci

OBJECTIVES: Determinants of atrial fibrillation (AF) patterns and of progression of earlier forms to permanent AF, and their relationship with outcome are still poorly understood. METHODS: We examined AF patterns (paroxysmal, persistent and permanent), rate and predictors of AF progression, and outcomes in the PREFER (PREvention oF thromboembolic events-European Registry) in AF. The primary analysis was performed in the PREFER in AF prolongation dataset (n=3223 patients with AF with a complete 1-year follow-up, mean age 72±9 years, 40% women). Sensitivity analyses were performed using the PREFER in the AF study (n=6390 patients). RESULTS: AF progressed to more persistent types in 506 patients (17%). Permanent AF was associated with development of heart failure at 1 year (OR 1.80, 95% CI 1.06 to 3.07, p=0.03) compared with paroxysmal AF, which was confirmed in the entire cohort. In multivariable-adjusted models, sinus rhythm at baseline, AF duration, cardioversion, hyperthyroidism, valvular heart disease, diabetes mellitus and heart failure were predictors of AF progression (area under the receiver operating characteristic curve 0.60, 95% CI 0.57 to 0.63). Results were similar when we restricted analyses to patients with AF duration <1 year. AF progression showed an association with coronary events over 1 year (OR 2.27, 95% CI 1.22 to 4.19, p=0.0074). CONCLUSIONS: Permanent AF at baseline was associated with incident heart failure. A substantial proportion of well-managed patients with AF showed AF progression over 1 year. AF progression itself was not strongly related to outcome and may indicate the need to refine the current classification of AF types to enhance clinical utility.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012772
003      
CZ-PrNML
005      
20190411133249.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/heartjnl-2017-312569 $2 doi
035    __
$a (PubMed)29550771
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a B Schnabel, Renate $u University Heart Center Hamburg Eppendorf, Hamburg, Germany. German Center for Cardiovascular Research (DZHK) partner site Hamburg/Kiel/Lübeck (RBS, DE, FMO), Berlin, Germany.
245    10
$a Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes / $c R. B Schnabel, L. Pecen, D. Engler, M. Lucerna, JM. Sellal, FM. Ojeda, R. De Caterina, P. Kirchhof,
520    9_
$a OBJECTIVES: Determinants of atrial fibrillation (AF) patterns and of progression of earlier forms to permanent AF, and their relationship with outcome are still poorly understood. METHODS: We examined AF patterns (paroxysmal, persistent and permanent), rate and predictors of AF progression, and outcomes in the PREFER (PREvention oF thromboembolic events-European Registry) in AF. The primary analysis was performed in the PREFER in AF prolongation dataset (n=3223 patients with AF with a complete 1-year follow-up, mean age 72±9 years, 40% women). Sensitivity analyses were performed using the PREFER in the AF study (n=6390 patients). RESULTS: AF progressed to more persistent types in 506 patients (17%). Permanent AF was associated with development of heart failure at 1 year (OR 1.80, 95% CI 1.06 to 3.07, p=0.03) compared with paroxysmal AF, which was confirmed in the entire cohort. In multivariable-adjusted models, sinus rhythm at baseline, AF duration, cardioversion, hyperthyroidism, valvular heart disease, diabetes mellitus and heart failure were predictors of AF progression (area under the receiver operating characteristic curve 0.60, 95% CI 0.57 to 0.63). Results were similar when we restricted analyses to patients with AF duration <1 year. AF progression showed an association with coronary events over 1 year (OR 2.27, 95% CI 1.22 to 4.19, p=0.0074). CONCLUSIONS: Permanent AF at baseline was associated with incident heart failure. A substantial proportion of well-managed patients with AF showed AF progression over 1 year. AF progression itself was not strongly related to outcome and may indicate the need to refine the current classification of AF types to enhance clinical utility.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    12
$a fibrilace síní $x klasifikace $x komplikace $x diagnóza $x epidemiologie $7 D001281
650    _2
$a diabetes mellitus $x diagnóza $x epidemiologie $7 D003920
650    12
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x diagnóza $x epidemiologie $7 D006333
650    _2
$a srdeční frekvence $7 D006339
650    _2
$a nemoci srdečních chlopní $x diagnóza $x epidemiologie $7 D006349
650    _2
$a lidé $7 D006801
650    _2
$a hypertyreóza $x diagnóza $x epidemiologie $7 D006980
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a hodnocení výsledků zdravotní péče $7 D017063
650    _2
$a management péče o pacienta $x metody $7 D010346
650    _2
$a registrace $x statistika a číselné údaje $7 D012042
650    _2
$a rizikové faktory $7 D012307
650    _2
$a tromboembolie $x etiologie $x prevence a kontrola $7 D013923
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Pecen, Ladislav $u Medical Faculty Pilsen of Charles University, Pilsen, Czech Republic.
700    1_
$a Engler, Daniel $u University Heart Center Hamburg Eppendorf, Hamburg, Germany. German Center for Cardiovascular Research (DZHK) partner site Hamburg/Kiel/Lübeck (RBS, DE, FMO), Berlin, Germany.
700    1_
$a Lucerna, Markus $u Daiichi Sankyo Europe, Munchen, Germany.
700    1_
$a Sellal, Jean Marc $u Departement de Cardiologie, Centre Hospitalier Universitaire de Nancy, Nancy, France.
700    1_
$a Ojeda, Francisco M $u University Heart Center Hamburg Eppendorf, Hamburg, Germany. German Center for Cardiovascular Research (DZHK) partner site Hamburg/Kiel/Lübeck (RBS, DE, FMO), Berlin, Germany.
700    1_
$a De Caterina, Raffaele $u G. d'Annunzio University, Chieti, Italy. Fondazione G. Monasterio, Pisa, Italy.
700    1_
$a Kirchhof, Paulus $u University of Birmingham SWBH, Birmingham, UK. UHB NHS Trust, Birmingham, UK.
773    0_
$w MED00002003 $t Heart (British Cardiac Society) $x 1468-201X $g Roč. 104, č. 19 (2018), s. 1608-1614
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29550771 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411133306 $b ABA008
999    __
$a ok $b bmc $g 1392082 $s 1051077
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 104 $c 19 $d 1608-1614 $e 20180317 $i 1468-201X $m Heart $n Heart $x MED00002003
LZP    __
$a Pubmed-20190405

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...